Astrocyte glutamate transporters are increased in an early sporadic model of synucleinopathy-Reference-Cited by-同舟云学术

Astrocyte glutamate transporters are increased in an early sporadic model of synucleinopathy

Published:2020-09 Issue: Volume:138 Page:104758
ISSN:0197-0186
Container-title:Neurochemistry International
language:en
Short-container-title:Neurochemistry International

Author:

Diniz Luan Pereira,Araujo Ana Paula Bérgamo,Matias Isadora,Garcia Matheus N.,Barros-Aragão Fernanda G.Q.,de Melo Reis Ricardo Augusto,Foguel Débora,Braga Carolina,Figueiredo Cláudia P.,Romão Luciana,Gomes Flávia Carvalho Alcantara

Funder

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro

Conselho Nacional de Desenvolvimento Científico e Tecnológico

Ministério da Saúde

Publisher

Elsevier BV

Subject

Cell Biology,Cellular and Molecular Neuroscience

Reference55 articles.

1. The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer;Bak;J. Neurochem.,2006

2. Neuronal activity regulates glutamate transporter dynamics in developing astrocytes;Benediktsson;Glia,2012

3. The anti-Parkinsonian drug selegiline delays the nucleation phase of alpha-synuclein aggregation leading to the formation of nontoxic species;Braga;J. Mol. Biol.,2011

4. Downregulation of glial glutamate transporters after dopamine denervation in the striatum of 6-hydroxydopamine-lesioned rats;Chung;J. Comp. Neurol.,2008

5. Neuro-glia interaction effects on GFAP gene: a novel role for transforming growth factor-beta1;de Sampaio e Spohr;Eur. J. Neurosci.,2002

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Region-specific changes in gene expression are associated with cognitive deficits in the alpha-synuclein-induced model of Parkinson's disease: A transcriptomic profiling study;Experimental Neurology;2024-02

2. Astrocytic transcription factors REST, YY1, and putative microRNAs in Parkinson’s disease and advanced therapeutic strategies;Gene;2024-01

3. Relationship among α‑synuclein, aging and inflammation in Parkinson's disease (Review);Experimental and Therapeutic Medicine;2023-11-21

4. α-Synuclein-carrying astrocytic extracellular vesicles in Parkinson pathogenesis and diagnosis;Translational Neurodegeneration;2023-08-25

5. Central nervous system demyelinating diseases: glial cells at the hub of pathology;Frontiers in Immunology;2023-05-16